Journal of Palliative MedicineVol. 15, No. 6 Letter to the EditorPatient Satisfaction with Intranasal Fentanyl for Breakthrough PainNicole M.L. Veldhorst-Janssen, Audrey A.A. Fiddelers, Heleen Zandstra, Alfons G.H. Kessels, Heleen Zandstra, Marco A.E. Marcus, Cees Neef, and Paul-Hugo M. van der KuyNicole M.L. Veldhorst-JanssenDepartment of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsSearch for more papers by this author, Audrey A.A. FiddelersDepartment of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsDepartment of Anaesthesiology, Maastricht University Medical Centre, Maastricht, The NetherlandsSearch for more papers by this author, Heleen ZandstraDepartment of Anaesthesiology, Maastricht University Medical Centre, Maastricht, The NetherlandsSearch for more papers by this author, Alfons G.H. KesselsDepartment of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The NetherlandsSearch for more papers by this author, Heleen ZandstraDepartment of Anaesthesiology, Maastricht University Medical Centre, Maastricht, The NetherlandsSearch for more papers by this author, Marco A.E. MarcusDepartment of Anaesthesiology, Maastricht University Medical Centre, Maastricht, The NetherlandsSearch for more papers by this author, Cees NeefDepartment of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsSearch for more papers by this author, and Paul-Hugo M. van der KuyDepartment of Clinical Pharmacology, Orbis Medical Center Sittard, Sittard, The Netherlands.Search for more papers by this authorPublished Online:1 Jun 2012https://doi.org/10.1089/jpm.2012.0013AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Patient Satisfaction with Intranasal Fentanyl for Breakthrough Pain." , 15(6), pp. 631–632FiguresReferencesRelatedDetailsCited byThe Use of Intranasal Fentanyl for the Palliation of Incident Dyspnea in Advanced Congestive Heart Failure: A Pilot Study31 May 2018 | Journal of Palliative Care, Vol. 34, No. 2Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis11 January 2017 | European Journal of Hospital Pharmacy, Vol. 25, No. 3Patient Satisfaction with Fentanyl Sublingual Spray in Opioid-Tolerant Patients with Breakthrough Cancer Pain25 July 2014 | Pain Practice, Vol. 15, No. 6Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain29 October 2014 | Supportive Care in Cancer, Vol. 23, No. 5Rapid-Onset Opioids for the Treatment of Breakthrough Cancer Pain: Two Cases of Drug Abuse: Table 11 May 2014 | Pain Medicine, Vol. 15, No. 5Fentanyl transmuqueux : évaluation pratique de son utilisation auprès des patients et des soignantsMédecine Palliative : Soins de Support - Accompagnement - Éthique, Vol. 13, No. 2 Volume 15Issue 6Jun 2012 InformationCopyright 2012, Mary Ann Liebert, Inc.To cite this article:Nicole M.L. Veldhorst-Janssen, Audrey A.A. Fiddelers, Heleen Zandstra, Alfons G.H. Kessels, Heleen Zandstra, Marco A.E. Marcus, Cees Neef, and Paul-Hugo M. van der Kuy.Patient Satisfaction with Intranasal Fentanyl for Breakthrough Pain.Journal of Palliative Medicine.Jun 2012.631-632.http://doi.org/10.1089/jpm.2012.0013Published in Volume: 15 Issue 6: June 1, 2012PDF download